Delivery Order SPE2DB20D7059-SPE2DB25FGRL2
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,208.12 on September 4, 2025, for the supply of Guaifenesin ER 600 mg tablets (500-count units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by September 5, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary pharmaceutical distribution...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract, valued at $4,201.22, is for the supply of the pharmaceutical product Guaifenesin 200mg/10ml. The contract has a firm fixed price pricing type and an ultimate completion date of November 12, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
- The Defense Logistics Agency awarded a $29,550 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200mg guaifenesin tablets. Under this order, Amerisourcebergen will deliver 100 bottles of the specified cough medication to a facility in Conshohocken, Pennsylvania by June 30, 2023 to support Department of Defense logistics operations. As a major pharmaceutical supplier, Amerisourcebergen frequently fulfills delivery orders for standard medical supplies through the DLA's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,389.38 on August 13, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count package). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 14, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $2,972.48 firm fixed-price delivery order is for the supply of Guaifenesin-DM 100-10 mg/5 ml unit dose 5 ml medication. The award has an ultimate completion date of May 13, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency awarded a delivery order valued at $3,631.68 to AmerisourceBergen Drug Corp for Mucinex D ER 600-60 mg tablets (18-count packages) on September 4, 2025, with an ultimate completion date of September 5, 2025. This competitive award, issued under firm fixed-price terms with no set-aside designation, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement. The contract will be performed at...
- The Defense Logistics Agency awarded a $737 delivery order to Amerisourcebergen Drug Corporation for 4561851739 GUAIFENESIN-PSE ER 600-60 MG 18S. The firm fixed price order is being fulfilled from the contractor's Conshohocken, Pennsylvania location to support DLA's medical supply needs. No additional details were provided regarding the original solicitation, but the award is for a pharmaceutical product to replenish Defense Department medical stock. Amerisourcebergen will serve as the prime...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Mucinex ER 600 mg tablets in quantities of 20 units, with a contract ceiling value of $1,392.98. This firm fixed-price delivery order is non-set-aside and carries an ultimate completion date of September 12, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,332.32 to AmerisourceBergen Drug Corp for Mucinex DM ER 600-30 mg tablets (20-count packages) with an ultimate completion date of September 11, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Mucinex D ER 600-60 mg tablets in quantities of 18 units. This firm fixed-price delivery order, valued at $10,118.97, is scheduled for completion by September 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation,...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FGRL2Delivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Guaifenesin ER 600 mg tablets (500 count) with a ceiling value of $1,419.55. The contract was awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, and utilizes firm fixed pricing with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite Delivery Contract vehicle with the DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, holds a substantial prime IDC with the DLA valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The company regularly fulfills federal medical procurement requirements through competitively awarded contracts spanning a broad spectrum of pharmaceutical products, generic and brand-name medications, vaccines, and medical supplies across multiple therapeutic domains. This award reflects AmerisourceBergen's established capability to support federal medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/10/25 |